Considering the fact that chemotherapy and photodynamic therapy are both oxygen or PD‐L1‐dependent tumor therapies, we firmly believe that TPP‐LND@Lip could also be applied to sensitize chemotherapy and photodynamic therapy. The gene discussed is CD274; the disease is neoplasm.